与阿尔茨海默病相关的步态研究取得了进展
Shuding Yan1, Xiaoping Yun2, Qiang Liu3
1Department of Neurology, The Third School of Clinical Medicine (School of Rehabilitation Medicine) of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Frontiers in neurology
|June 18, 2025
概括
步态分析与机器学习相结合,对早期发现阿尔茨海默病 (AD) 显示出前途. 这种方法可以提供一种非侵入性,对认知衰退的客观生物标志物,有助于早期痴呆症诊断.
科学领域:
- 神经科学是一个神经科学.
- 生物医学工程 生物医学工程
- 人工智能的人工智能
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,没有确定的治疗方法.
- 目前的AD早期检测方法可能是侵入性的和昂贵的.
- 新出现的证据将步态模式与认知功能联系起来,表明步态作为潜在的诊断标记.
研究的目的:
- 在阿尔茨海默病中对临床步态评估进行范围审查.
- 探索步态分析,机器学习和AD的认知状态之间的关系.
- 确定步态分析作为早期AD检测的客观生物标志物的潜力.
主要方法:
- 在PubMed进行了全面的文献搜索,截至2024年3月18日.
- 关键词包括"机器学习和步行"和"步行和阿尔茨海默病".
- 符合选择标准的原始研究文章被纳入审查.
主要成果:
- 步态特征和认知属性之间存在显著的相关性.
- 3D步态分析系统可以捕获AD患者的步态数据.
- 基于图形神经网络的机器学习可以从步态数据中识别AD,从而促进早期检测.
结论:
- 步态分析为早期发现阿尔茨海默病提供了一种可行的客观方法.
- 应用于步态数据的机器学习可以作为认知衰退的非侵入性生物标志物.
- 对步行认知相互作用的进一步研究对于完善诊断工具至关重要.
相关概念视频
01:26Alzheimer's Disease: Overview
686
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
686
01:22Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265